These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 32412352)
21. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Uner M Pharmazie; 2006 May; 61(5):375-86. PubMed ID: 16724531 [TBL] [Abstract][Full Text] [Related]
22. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. Jores K; Haberland A; Wartewig S; Mäder K; Mehnert W Pharm Res; 2005 Nov; 22(11):1887-97. PubMed ID: 16132349 [TBL] [Abstract][Full Text] [Related]
23. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration. Fonseca-Santos B; Silva PB; Rigon RB; Sato MR; Chorilli M Curr Med Chem; 2020; 27(22):3623-3656. PubMed ID: 31232233 [TBL] [Abstract][Full Text] [Related]
24. UV Spectrophotometric method for characterization of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: Method development, in-vitro and ex-vivo applications in topical delivery. Rapalli VK; Kaul V; Gorantla S; Waghule T; Dubey SK; Pandey MM; Singhvi G Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jan; 224():117392. PubMed ID: 31330421 [TBL] [Abstract][Full Text] [Related]
25. Effects of a lycopene-layered double hydroxide composite administration in cells and lungs of adult mice. de Carvalho IM; de Souza ABF; Castro TF; Machado-Júnior PA; Menezes TP; Dias ADS; Oliveira LAM; Nogueira KOPC; Talvani A; Cangussú SD; Arízaga GGC; Bezerra FS Int Immunopharmacol; 2023 Aug; 121():110454. PubMed ID: 37301124 [TBL] [Abstract][Full Text] [Related]
26. LYC loaded ferritin nanoparticles for intracerebral delivery and the attenuation of neurodegeneration in D-gal-induced mice. Xia X; Li H; Xu X; Wu C; Wang Z; Yi J; Zhao G; Du M Biomater Adv; 2023 Aug; 151():213419. PubMed ID: 37148595 [TBL] [Abstract][Full Text] [Related]
27. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Elnaggar YS; El-Massik MA; Abdallah OY Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508 [TBL] [Abstract][Full Text] [Related]
28. Preparation and in vitro investigation of prostate-specific membrane antigen targeted lycopene loaded niosomes on prostate cancer cells. Kusdemir BC; Kozgus Guldu O; Yurt Kilcar A; Medine EI Int J Pharm; 2023 Jun; 640():123013. PubMed ID: 37149111 [TBL] [Abstract][Full Text] [Related]
29. Lipid-Based Nanostructures for the Delivery of Natural Antimicrobials. Pinilla CMB; Lopes NA; Brandelli A Molecules; 2021 Jun; 26(12):. PubMed ID: 34208209 [TBL] [Abstract][Full Text] [Related]
30. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015 [TBL] [Abstract][Full Text] [Related]
31. Development of Lipid-Based Nanocarriers for Increasing Gastrointestinal Absorption of Lupinifolin. Musika J; Chudapongse N Planta Med; 2020 Mar; 86(5):364-372. PubMed ID: 32005042 [TBL] [Abstract][Full Text] [Related]
32. [Effect of nanostructured lipid carriers (NLCs) in improving stability of essential oils and its application]. Li Y; Wu ZF; Kuang WW; Li YH; Chen BY; Yang M Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):523-530. PubMed ID: 32237509 [TBL] [Abstract][Full Text] [Related]
33. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation. Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655 [TBL] [Abstract][Full Text] [Related]
34. SLN and NLC for topical, dermal, and transdermal drug delivery. Souto EB; Baldim I; Oliveira WP; Rao R; Yadav N; Gama FM; Mahant S Expert Opin Drug Deliv; 2020 Mar; 17(3):357-377. PubMed ID: 32064958 [No Abstract] [Full Text] [Related]
35. Solid lipid nanocarriers in drug delivery: characterization and design. Mu H; Holm R Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267 [TBL] [Abstract][Full Text] [Related]
36. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation. Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680 [TBL] [Abstract][Full Text] [Related]
37. SLN and NLC for topical delivery of ketoconazole. Souto EB; Müller RH J Microencapsul; 2005 Aug; 22(5):501-10. PubMed ID: 16361193 [TBL] [Abstract][Full Text] [Related]
38. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam. Dasgupta S; Ray S; Dey S; Pal P; Mazumder B Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909 [TBL] [Abstract][Full Text] [Related]
39. Short Term Stability Testing of Efavirenz-Loaded Solid Lipid Nanoparticle (SLN) and Nanostructured Lipid Carrier (NLC) Dispersions. Makoni PA; Wa Kasongo K; Walker RB Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31398820 [TBL] [Abstract][Full Text] [Related]
40. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins. Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]